Recombinant Human Papilloma Virus 16 Capsid Protein (HPV-16 L1) antibody

Catalog No. ABIN5707603

The Mouse Monoclonal anti-Human Papilloma Virus 16 Capsid Protein antibody (Clone rHPV16L1-1058) (ABIN5707603) specifically detects Human Papilloma Virus 16 Capsid Protein in IHC (p). The antibody is reactive with Human Papillomavirus 16 (HPV-16) samples.

Quick Overview for Recombinant Human Papilloma Virus 16 Capsid Protein (HPV-16 L1) antibody (ABIN5707603)

Target: Human Papilloma Virus 16 Capsid Protein (HPV-16 L1)

Antibody Type: Recombinant Antibody

Reactivity: Human Papillomavirus 16 (HPV-16)

Host: Mouse

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: RHPV16L1-1058

Product Details

Purpose: Recombinant HPV16 L1 Antibody (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogen: Recombinant human papilloma virus type 16, major capsid protein L1, was used as the immunogen for the recombinant HPV16 L1 antibody.

Isotype: IgG1

Application Details

Application Notes: Optimal dilution of the recombinant HPV16 L1 antibody should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: 4 °C,-20 °C

Storage Comment: Store the recombinant HPV16 L1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details

Target: Human Papilloma Virus 16 Capsid Protein (HPV-16 L1)

Alternative Name: HPV16 L1

Target Type: Viral Protein

Background: Reacts with a protein of 57 kDa, identified as the L1 protein of human papilloma virus type 16 (HPV-16). It is the major capsid protein of HPV-16. Infection with specific types of HPV has been associated with an increased risk of developing cervical neoplasia. HPV types 6 and 11 have been associated with relatively benign diseases such as genital warts but types 16 and 18 are strongly associated with cervical, vaginal, and vulvar malignancies. The antibody reacts very strongly with formalin-fixed, paraffin-embedded tissues containing HPV-16 or -33, very weak reactions were occasionally observed with biopsy specimens or smears containing HPV-6 or HPV-11. It cross-reacts with HPV37.

UniProt: P03101